PPBT
Purple Biotech
PPBT
PPBT
11 hedge funds and large institutions have $5.27M invested in Purple Biotech in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
11
Holding in Top 10
–
Calls
$1.29M
Puts
$518K
Top Buyers
| 1 | +$3.37M | |
| 2 | +$57K | |
| 3 | +$46K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$21K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$247K | |
| 3 | -$138K | |
| 4 |
O
OrbiMed
New York
|
-$86K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$79.5K |